New cancer clinical trial: Atezolizumab Given in Combination With a Personalized Vaccine in Patients With Urothelial Cancer

Published on: December 01, 2017 at 10:00AM
Condition:   Urothelial/Bladder Cancer, Nos
Interventions:   Drug: Atezolizumab;   Biological: PGV001;   Drug: Poly ICLC;   Drug: Normal saline
Sponsors:   Matthew Galsky;   Genentech, Inc.
Not yet recruiting
http://ift.tt/2zWr7Hc